Understanding the roles of MaR1 and CHI3L1 in the inflammatory and fibrotic processes associated with diabetes and diabetic nephropathy may facilitate the identification of novel targets for early diagnosis and therapeutic intervention. This evidence concerns the gene CHI3L1 and diabetic kidney disease.